Target intelligence / Profile preview

Tsukushi, small leucine-rich proteoglycan (TSKU)

Target
TSKU
Molecular classification
Extracellular matrix protein, Small leucine-rich proteoglycan (SLRP), class IV
01

Overview

Tsukushi, small leucine-rich proteoglycan (TSKU) is a class IV extracellular matrix proteoglycan protein encoded by the TSKU gene, predominantly found in the extracellular space and involved in regulation of multiple developmental and metabolic processes. It directly binds and antagonizes growth factors and signaling molecules such as TGF-β and components of the Wnt pathway, modulating cell fate, differentiation, bone and cartilage growth, cholesterol homeostasis, wound healing, hair follicle cycling, and neural stem cell differentiation. Tsukushi also influences RNA splicing networks and gene regulation, particularly in neural stem cells and developing tissues. Dysfunction or altered expression of tsukushi is implicated in developmental disorders (including hydrocephalus), certain cancers, and abnormalities in bone and tissue growth, but to date, there are no drugs specifically targeting the protein, though its pathway regulatory roles render it of high interest for possible future therapeutic targeting.

Other names
TSKTsukushiLRRC54E2IG4TsukushinE2-induced gene 4 proteinLeucine-rich repeat-containing protein 54Tsukushi homologsmall leucine-rich proteoglycanUNQ850/PRO1788
02

Mechanism of action

Not applicable

03

Biological functions

Regulation of Wnt signaling (inhibitor)Transforming growth factor-beta (TGF-β) binding/antagonismBone and cartilage growth regulationCell fate specification and differentiationMaintenance of neural stem cell fateRegulation of cholesterol homeostasisControl of hair follicle cyclingWound healing modulationRNA splicing maintenance
04

Disease associations

Neurodevelopmental disorders (e.g., hydrocephalus)Cancer (associated with malignant transformation in prostate tissue)Gallbladder neoplasmsAbnormalities in bone and cartilage growthDevelopmental disorders (eye, brain, ear)
05

Safety considerations

Potential off-target effects if manipulated during development due to broad role in multiple pathways (e.g., Wnt, TGF-β, SHH, mTOR)Impacts on neurogenesis and neural stem cell fate if disrupted
06

Interacting drugs

None reported
07

Biomarkers

Expression of TSKU/TSK in neural tissues

Beyond the preview

Go deeper on Tsukushi, small leucine-rich proteoglycan (TSKU).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tsukushi, small leucine-rich proteoglycan (TSKU).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call